112 related articles for article (PubMed ID: 8320172)
1. Detection of active form of transforming growth factor-beta in cerebrospinal fluid of patients with glioma.
Tada T; Yabu K; Kobayashi S
Jpn J Cancer Res; 1993 May; 84(5):544-8. PubMed ID: 8320172
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response to p53 in malignant glioma.
Weller M; Bornemann A; Ständer M; Schabet M; Dichgans J; Meyermann R
J Neurol; 1998 Mar; 245(3):169-72. PubMed ID: 9553848
[TBL] [Abstract][Full Text] [Related]
3. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid.
Johnson MD; Gold LI; Moses HL
Lab Invest; 1992 Sep; 67(3):360-8. PubMed ID: 1328762
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma, transforming growth factor-beta, and Candida meningitis: a potential link.
Peterson PK; Chao CC; Hu S; Thielen K; Shaskan EG
Am J Med; 1992 Mar; 92(3):262-4. PubMed ID: 1312305
[TBL] [Abstract][Full Text] [Related]
5. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
Qu K; Lin T; Pang Q; Liu T; Wang Z; Tai M; Meng F; Zhang J; Wan Y; Mao P; Dong X; Liu C; Niu W; Dong S
Oncotarget; 2016 Jun; 7(23):33994-4010. PubMed ID: 27166186
[TBL] [Abstract][Full Text] [Related]
6. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
7. Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells.
Satoh E; Naganuma H; Sasaki A; Nagasaka M; Ogata H; Nukui H
J Neurooncol; 1997 Jul; 33(3):195-200. PubMed ID: 9195490
[TBL] [Abstract][Full Text] [Related]
8. The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.
Jachimczak P; Bogdahn U; Schneider J; Behl C; Meixensberger J; Apfel R; Dörries R; Schlingensiepen KH; Brysch W
J Neurosurg; 1993 Jun; 78(6):944-51. PubMed ID: 8487077
[TBL] [Abstract][Full Text] [Related]
9. Production of a bioactive high molecular weight transforming growth factor beta-like molecule by human malignant glioma cell lines.
Tucker MA; Gillespie GY
Growth Factors; 1994; 11(2):153-62. PubMed ID: 7857659
[TBL] [Abstract][Full Text] [Related]
10. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
[TBL] [Abstract][Full Text] [Related]
11. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Kuratsu J; Yoshizato K; Yoshimura T; Leonard EJ; Takeshima H; Ushio Y
J Natl Cancer Inst; 1993 Nov; 85(22):1836-9. PubMed ID: 8230263
[TBL] [Abstract][Full Text] [Related]
12. Detection of transforming growth factor beta 1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization.
Ossege LM; Voss B; Wiethege T; Sindern E; Malin JP
J Neurol; 1994 Dec; 242(1):14-9. PubMed ID: 7897447
[TBL] [Abstract][Full Text] [Related]
13. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
[TBL] [Abstract][Full Text] [Related]
15. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
16. [Cerebrospinal fluid proteins in cerebral neoplasms].
RESTI M
Riv Patol Clin; 1961 Dec; 16():829-36. PubMed ID: 14491577
[No Abstract] [Full Text] [Related]
17. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
[TBL] [Abstract][Full Text] [Related]
19. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
20. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
